Sihuan Pharmaceutical Holdings Group Ltd
Company Profile
Business description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Contact
Zhubang 2000
22nd Floor, Building 4
West Balizhuang, Chaoyang District
Beijing100025
CHNT: +86 1057693700
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,767
Stocks News & Analysis
stocks
Alibaba fair value increases by 49%
stocks
A 5-Star US stock to buy with a near-5% yield
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,148.50 | 45.40 | 0.50% |
CAC 40 | 7,883.96 | 13.28 | 0.17% |
DAX 40 | 23,743.27 | 3.80 | 0.02% |
Dow JONES (US) | 46,247.29 | 299.97 | 0.65% |
FTSE 100 | 9,337.90 | 53.07 | 0.57% |
HKSE | 26,622.88 | 494.68 | 1.89% |
NASDAQ | 22,484.07 | 99.37 | 0.44% |
Nikkei 225 | 45,043.75 | 311.24 | -0.69% |
NZX 50 Index | 13,132.56 | 20.83 | 0.16% |
S&P 500 | 6,643.70 | 38.98 | 0.59% |
S&P/ASX 200 | 8,862.80 | 52.10 | 0.59% |
SSE Composite Index | 3,862.53 | 34.43 | 0.90% |